Therapy with angiotensin-converting enzyme inhibitors and nonselective vasodilators
(hydralazine and isosorbide dinitrate) has become accepted treatment in patients with …

Summary The Veterans Affairs Vasodilator-Heart Failure Trials (V-HeFT I and II) provided
information about heart failure treated with conventional therapy, and evaluated the long …

Abstract Background and Methods. To define better the efficacy of vasodilator therapy in the
treatment of chronic congestive heart failure, we compared the effects of hydralazine and …

Congestive heart failure (CHF) causes disabling symptoms and increases the likelihood of
decreased survival. Diuretics, direct vasodilators, and angiotensin‐converting enzyme …

Background Despite therapy with diuretics, ACE inhibitors and digoxin morbidity and
mortality in heart failure remain high and might respond favorably to an additional …

OBJECTIVE--To compare the effects of felodipine and placebo in patients with New York
Heart Association functional class II or III and stable congestive heart failure despite …

In this article literature concerning the major drugs used in the treatment of heart failure is
reviewed. Because of major discrepancies in results from short term and uncontrolled …

Short-term goals of heart failure management are directed toward relieving symptoms such
as shortness of breath, decreased exercise tolerance, and lower-extremity edema and …

Despite recent evidence that angiotensin‐converting enzyme (ACE) inhibitors reduce
mortality in patients with congestive heart failure (CHF), it is important to note that roughly …

The results after the first 6 months of the 1-year treatment of this multicenter, randomized,
open, parallel-group design study of delapril versus enalapril in patients with congestive …